北交所本周跌幅领先，医药生物赛道涨幅居前

Investment Rating - The report maintains an "Accumulate" rating for the industry [1]. Core Insights - The overall market performance of the North Exchange shows a decline, with the North Exchange 50 Index dropping by 2.46% to close at 1419.61 points, while the Shanghai and Shenzhen 300 Index, ChiNext Index, and Sci-Tech 50 Index fell by 1.96%, 1.69%, and 1.74% respectively [5][12]. - The top five performing sectors in the A-share market this week were pharmaceuticals and biotechnology, communications, media, leisure services, and mining, with respective gains of 1.46%, 1.29%, 1.19%, 0.28%, and 0.00% [5][17]. - Among the 269 listed companies on the North Exchange, 51 stocks rose, 218 fell, and none remained flat, resulting in a rise ratio of 19% [5][19]. Summary by Sections North Exchange Market Overview - As of August 3, 2025, the North Exchange comprises 269 constituent stocks with an average market capitalization of 3.113 billion [5][12]. - The average daily trading volume for the North Exchange A-shares reached 25.7 billion, a decrease of 17% from the previous week, with a turnover rate of 5.94% [15]. North Exchange New Stocks - No new stocks were issued this week. As of July 28 to August 3, 2025, 22 companies updated their review status to "inquired," while 1 company was approved for the listing committee meeting, and 1 company was terminated [7][25]. North Exchange Key Announcements - Three key companies, Taihu Snow, Parallel Technology, and Minshida, released their semi-annual reports for 2025, all reporting net profit growth [30]. North Exchange Investment Strategy - The report suggests focusing on high-quality development in 2025, highlighting potential opportunities in data centers, robotics, semiconductors, consumer goods, and military information technology [31].